Search Results

Press Releases

IQVIA Reports Third-Quarter 2024 Results and Announces Investor Day

October 31, 2024

·

19 min read

Business

IQVIA Reports First-Quarter 2024 Results

IQVIA Holdings Inc., a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, reported financial results for the quarter ended March 31, 2024.

May 2, 2024

·

18 min read

Press Releases

IQVIA CFO Ron Bruehlman to Speak at the UBS Global Healthcare Conference on November 13, 2024

November 7, 2024

·

1 min read

Business

IQVIA to Announce Third-Quarter 2024 Results on October 31, 2024

October 15, 2024

·

2 min read

Business

IQVIA to Announce First-Quarter 2024 Results on May 2, 2024

IQVIA Holdings Inc. will announce its first-quarter 2024 financial results before the market opens on Thursday, May 2, 2024.

April 15, 2024

·

2 min read

Bio NC

IQVIA Publishes its 2023 Environmental, Social and Governance Report

IQVIA™ (NYSE:IQV), has published its 2023 Environmental, Social and Governance (ESG) Report.

February 26, 2024

·

4 min read

Bio NC

IQVIA and Salesforce Expand Global Partnership to Accelerate the Development of Life Sciences Cloud

IQVIA and Salesforce announced an expanded global strategic partnership to accelerate the development of Salesforce’s Life Sciences Cloud, a next-generation customer engagement platform for the global life sciences industry.

April 8, 2024

·

4 min read

Bio NC

IQVIA CFO Ron Bruehlman to Speak at the Bank of America Health Care Conference on May 14, 2024

IQVIA Holdings Inc. announced that Ron Bruehlman, executive vice president and chief financial officer, will speak at the Bank of America Health Care Conference in Las Vegas on Tuesday, May 14, 2024 at 12:20 p.m. ET.

May 9, 2024

·

1 min read

Business

IQVIA Reports Fourth-Quarter and Full-Year 2023 Results; Issues Full-Year 2024 Guidance

IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today reported financial results for the quarter ended December 31, 2023.

February 14, 2024

·

21 min read

Business

IQVIA’s Christina Mack Named 2023 PharmaVoice 100 Honoree

IQVIA™ (NYSE:IQV), a global provider of data, analytics, technology solutions and services to the life sciences industry, announced that Dr. Christina Mack, chief scientific officer, has been named to the 2023 PharmaVoice 100 list.

November 6, 2023

·

3 min read